#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small intestine leiomyosarcoma Hypoxic-ischaemic encephalopathy Osteomyelitis Optic glioma Immune-mediated myositis Glycogen storage disease type I Antiphospholipid syndrome Colitis ulcerative Acute respiratory distress syndrome Infective uveitis Skin angiosarcoma Mantle cell lymphoma recurrent Palmoplantar pustulosis Vascular calcification Chronic graft versus host disease More trials…

    Learn about Rare Diseases

    Hypereosinophilic syndrome – Treatment Osteosarcoma recurrent – Diagnostics Congenital generalised lipodystrophy – Treatment Adrenogenital syndrome – Life with Disease Angiosarcoma non-metastatic – Life with Disease Haemophagocytic lymphohistiocytosis Haemophilia A without inhibitors Angiosarcoma – Trials in Disease Indolent systemic mastocytosis – Diagnostics Mast cell activation syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Escitalopram Oxalate Ammonium Chloride Bp Levocetirizine Dihydrochloride OMTX705 Cpk850 FLUORIDE Hmb-001 Ticagrelor Anhydrous Glucose Bp Blinatumomab Fentanyl Citrate Lufepirsen ABBV-8736 Bidridistrogene Xeboparvovec Gad20-209-Fsp-A3 Pramipexole BIIB115 Omaveloxolone Litenimod Sodium Lsta1 More therapies…

    Learn about Your Condition

    Colorectal adenocarcinoma Neck pain Antisynthetase syndrome Peritoneal abscess Diabetic gastroparesis Anxiety Chordoma Intermittent claudication Congenital aplastic anaemia Prostate cancer recurrent Urea cycle disorder Pulmonary resection Decreased appetite Hepatitis D Hernia repair More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on Personalized Treatment for Metastatic Colorectal Cancer Using Regorafenib for Patients with Advanced Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Regorafenib
    France

  • Study of Nivolumab for Patients with Esophageal Cancer Undergoing Active Surveillance After Chemoradiation

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    Investigated Drugs:
    • Nivolumab
    The Netherlands

  • Study of Elafibranor in Adults with Primary Biliary Cholangitis Who Don’t Respond Well to or Cannot Tolerate Ursodeoxycholic Acid Treatment

    Not recruiting

    3 1
    Investigated Drugs:
    • Elafibranor
    Czechia France Germany Italy Poland Romania +1

  • Study of SGM-101 fluorescent imaging agent to guide surgery in patients with pancreatic cancer who received prior treatment

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Ductal adenocarcinoma of pancreas
    Investigated Drugs:
    • Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen Conjugated To Fluorochrome Bm-104
    The Netherlands

  • Study of Tulisokibart for Patients with Moderately to Severely Active Ulcerative Colitis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Tulisokibart
    Czechia France Hungary Poland

  • Safety Study of Almagate for Pregnant Women with Heartburn and Reflux, Assessing Effects on Mother and Baby

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Dyspepsia
    • Gastrooesophageal reflux disease
    Investigated Drugs:
    • Almagate
    Spain
Previous Page
1 … 70 71 72 73 74 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!